Skip to content
10-Q

Quarterly Report

LEXARIA BIOSCIENCE CORP. LEXX

0001640334-26-000080

← back to feed
Filed
Jan 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Jan 13, 2026 24.89M sh
Shares Diluted Q1 2026 · Nov 30, 2025 21.38M sh
Shares Diluted Q1 2026 · Nov 30, 2024 16.67M sh
Capex Q1 2026 · Nov 30, 2025 $0
Capex Q1 2026 · Nov 30, 2024 $24.65K
Operating Cash Flow Q1 2026 · Nov 30, 2025 −$984.1K
Operating Cash Flow Q1 2026 · Nov 30, 2024 −$2.73M
Short Term Investments Q1 2026 · Nov 30, 2025 $143.27K
Short Term Investments Q1 2026 · Aug 31, 2025 $143.27K
Cash And Equivalents Q1 2026 · Nov 30, 2025 $4.3M
Stockholders Equity Q1 2026 · Nov 30, 2025 $4.91M
Stockholders Equity Q1 2026 · Aug 31, 2025 $2.99M
Current Liabilities Q1 2026 · Nov 30, 2025 $1.46M
Current Liabilities Q1 2026 · Aug 31, 2025 $1.49M
Total Liabilities Q1 2026 · Nov 30, 2025 $1.53M
Total Liabilities Q1 2026 · Aug 31, 2025 $1.57M
Current Assets Q1 2026 · Nov 30, 2025 $5.36M
Current Assets Q1 2026 · Aug 31, 2025 $3.47M
Total Assets Q1 2026 · Nov 30, 2025 $6.05M
Total Assets Q1 2026 · Aug 31, 2025 $4.18M
Eps Diluted Q1 2026 · Nov 30, 2025 −$0.07
Eps Diluted Q1 2026 · Nov 30, 2024 −$0.16
Sga Expense Q1 2026 · Nov 30, 2025 $902.29K
Sga Expense Q1 2026 · Nov 30, 2024 $918.69K
Rd Expense Q1 2026 · Nov 30, 2025 $671.34K
Rd Expense Q1 2026 · Nov 30, 2024 $1.95M
Net Income Q1 2026 · Nov 30, 2025 −$1.6M
Net Income Q1 2026 · Nov 30, 2024 −$2.7M
Operating Income Q1 2026 · Nov 30, 2025 −$1.57M
Operating Income Q1 2026 · Nov 30, 2024 −$2.69M
Gross Profit Q1 2026 · Nov 30, 2025 $0
Gross Profit Q1 2026 · Nov 30, 2024 $181.2K